LDN Website Update - January 23, 2007

[Guest guest]

LDN Website Update - January 23, 2007

www.low dose naltrexone.org / www.ldninfo.org

Latest News As of January 2007:

First Study of LDN Published in US Medical Journal

Dr. Jill 's original article, " Low-Dose Naltrexone Therapy Improves Active

Crohn's

Disease, " in the current issue of the American Journal of Gastroenterology

(2007;102:1–9),

officially presents LDN to the world of scientific medicine. , Professor of

Gastroenterology at Pennsylvania State University's College of Medicine, found

that two-

thirds of the patients in her pilot study went into remission and fully 89% of

the group

responded to treatment to some degree. She concluded that " LDN therapy appears

effective and safe in subjects with active Crohn's disease. " (For further

information on

's study, please see the linked Clinical Trials page.)

LDN Meeting Planned at the NIH

Abrams, M.D., Chief of the Clinical Investigations Branch at the

National Cancer

Institute, is arranging a meeting at the NCI in order to acquaint staff

researchers from

various of the National Institutes of Health—those involved with autoimmune

diseases,

neurological disorders, AIDS and cancer—with some of the research opportunities

presented by LDN, metenkephalin (an endorphin-like substance produced in the

adrenal

medulla) and related drugs. Abrams plans to hold a half-day conference on

Friday, April

20th, 2007 in Bethesda, land. Invitees thus far include I. Zagon, PhD; Jill

P. , MD;

Hong, PhD; and Plotnikoff, PhD; as well as physician practitioners

with

experiences in LDN treatment. This appears to be a long-sought opportunity to

present

the story of LDN and associated substances to one of the foremost research

institutions in

the world.

(Corresponding changes and additional updates have also been made to " Clinical

Trials for

LDN " and other pages.)

LDN Website Editors

email@...